TAILORED-TreatmentProject ID: 602860
DEVELOPMENT OF TAILORED ANTIMICROBIAL TREATMENT REGIMENS AND NOVEL HOST- PATHOGEN INSIGHTS FOR RESPIRATORY TRACT INFECTIONS AND SEPSIS
Total cost:EUR 7 767 671,99
EU contribution:EUR 5 975 383
Call for proposal:FP7-HEALTH-2013-INNOVATION-1See other projects for this call
Funding scheme:CP-FP - Small or medium-scale focused research project
Though of tremendous benefit, the overuse of antibiotics has lead to the emergence of antibiotic resistance and may cause adverse events that impact on patient healthcare. Current diagnostic tools for facilitating the appropriate use of antibiotics in patients are inadequate.
We will establish a broad-based strategy (not limited to a particular antibiotic group) that can be implemented on a broad scale to increase the effectiveness of antimicrobial therapy, reduce adverse events, and help limit the emergence of antimicrobial resistance in children and adults.
At the heart of the TAILORED-Treatment project is a prospective clinical study in which we will recruit 1200 patients (>2000 patient samples) presenting with respiratory tract infections and/or sepsis. Patient cohorts will include equal representation of genders, children and adults. State-of-the-art molecular technologies will be applied to characterize host-pathogen interactions at the genomic, transcriptomic, proteomic and clinical level, resulting in a large-scale and unique multi-dimensional dataset. The consortium partners will develop new computational tools to interrogate this data, in order to provide new insights into personalized host-pathogen interactions, including the discovery of novel biomarkers for physicians to use in patient diagnosis and disease monitoring.
Concurrently, using this data, we will construct a predictive personalized treatment algorithm that will lead to informed and personalized antimicrobial treatment regimens (indication, dosage, and duration) that are tailored to the needs (type of infection, presence of novel biomarkers etc) of children and adults presenting with respiratory infections and sepsis.
This unique multi-dimensional dataset and personalized predictive treatment algorithm will be built into an easily navigable web-based, free-to-use, decision support system for use by physicians to explore and assist in patient-tailored antimicrobial treatment decisions.
EU contribution: EUR 1 438 430
's Gravendijkwal 230
Tel.: +31 107032177
Fax: +31 107033875
EU contribution: EUR 257 000
HAALON STREET 16A
EU contribution: EUR 729 987
3584 CX UTRECHT
Tel.: +31 887554001
EU contribution: EUR 496 381,40
Tel.: +972 26778960
Fax: +972 26434579
EU contribution: EUR 1 512 452,80
NAHUM HETH STREET 5
39120 TIRAT CARMEL
Tel.: +972 48500302
Fax: +972 48500298
EU contribution: EUR 1 012 720
405 30 GOETEBORG
Tel.: +46 31 786 6470
Fax: +46 31 786 4355
EU contribution: EUR 528 411,80
PARQUE TECNOLOGICO 801A
Tel.: +34 944036998
Fax: +34 944036999